Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

606 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Author Correction: Vepafestinib is a pharmacologically advanced RET-selective inhibitor with high CNS penetration and inhibitory activity against RET solvent front mutations.
Miyazaki I, Odintsov I, Ishida K, Lui AJW, Kato M, Suzuki T, Zhang T, Wakayama K, Kurth RI, Cheng R, Fujita H, Delasos L, Vojnic M, Khodos I, Yamada Y, Ishizawa K, Mattar MS, Funabashi K, Chang Q, Ohkubo S, Yano W, Terada R, Giuliano C, Lu YC, Bonifacio A, Kunte S, Davare MA, Cheng EH, de Stanchina E, Lovati E, Iwasawa Y, Ladanyi M, Somwar R. Miyazaki I, et al. Among authors: ishizawa k. Nat Cancer. 2023 Oct;4(10):1526. doi: 10.1038/s43018-023-00663-3. Nat Cancer. 2023. PMID: 37814012 Free PMC article. No abstract available.
Vepafestinib is a pharmacologically advanced RET-selective inhibitor with high CNS penetration and inhibitory activity against RET solvent front mutations.
Miyazaki I, Odintsov I, Ishida K, Lui AJW, Kato M, Suzuki T, Zhang T, Wakayama K, Kurth RI, Cheng R, Fujita H, Delasos L, Vojnic M, Khodos I, Yamada Y, Ishizawa K, Mattar MS, Funabashi K, Chang Q, Ohkubo S, Yano W, Terada R, Giuliano C, Lu YC, Bonifacio A, Kunte S, Davare MA, Cheng EH, de Stanchina E, Lovati E, Iwasawa Y, Ladanyi M, Somwar R. Miyazaki I, et al. Among authors: ishizawa k. Nat Cancer. 2023 Sep;4(9):1345-1361. doi: 10.1038/s43018-023-00630-y. Epub 2023 Sep 21. Nat Cancer. 2023. PMID: 37743366 Free PMC article.
Oral alkalinizing supplementation suppressed intrarenal reactive oxidative stress in mild-stage chronic kidney disease: a randomized cohort study.
Abe M, Yamaguchi T, Koshiba S, Takayama S, Nakai T, Nishioka K, Yamasaki S, Kawaguchi K, Umeyama M, Masaura A, Ishizawa K, Arita R, Kanno T, Akaishi T, Miyazaki M, Abe T, Tanaka T, Ishii T; CKOALA study group. Abe M, et al. Among authors: ishizawa k. Clin Exp Nephrol. 2024 Nov;28(11):1134-1154. doi: 10.1007/s10157-024-02517-3. Epub 2024 Jun 13. Clin Exp Nephrol. 2024. PMID: 38872014 Free PMC article. Clinical Trial.
Sequential Sampling of the Gastrointestinal Tract to Characterize the Entire Digestive Microbiome in Japanese Subjects.
Ishizawa K, Tamahara T, Suzuki S, Hatayama Y, Li B, Abe M, Aoki Y, Arita R, Saito N, Ohsawa M, Kaneko S, Ono R, Takayama S, Shimada M, Kumada K, Koike T, Masamune A, Onodera K, Ishii T, Shimizu R, Kanno T. Ishizawa K, et al. Microorganisms. 2024 Jun 28;12(7):1324. doi: 10.3390/microorganisms12071324. Microorganisms. 2024. PMID: 39065094 Free PMC article.
A phase II study of zandelisib in patients with relapsed or refractory indolent non-Hodgkin lymphoma: ME-401-K02 study.
Munakata W, Kumode T, Goto H, Fukuhara N, Shimoyama T, Takeuchi M, Kawakita T, Kubo K, Sawa M, Uchida T, Mishima Y, Ichii M, Hanaya M, Matsumoto A, Kuriki M, Seike T, Izutsu K, Ishizawa K. Munakata W, et al. Among authors: ishizawa k. Br J Haematol. 2025 Jan 8. doi: 10.1111/bjh.19994. Online ahead of print. Br J Haematol. 2025. PMID: 39778876
A case of the iatrogenic transmission of vascular Aß40 amyloid.
Kawarabayashi T, Nakamura T, Takatama S, Miyamoto N, Iwai T, Naito I, Sugawara T, Ishizawa K, Hashimoto K, Amari M, Ikeuchi T, Kasahara H, Ikeda Y, Takatama M, Shoji M. Kawarabayashi T, et al. Among authors: ishizawa k. Amyloid. 2024 Oct 29:1-3. doi: 10.1080/13506129.2024.2419857. Online ahead of print. Amyloid. 2024. PMID: 39470140 No abstract available.
Assessing the effects of interprofessional education by hospital pharmacists on pharmaceutical students using a self-evaluation scale.
Aizawa F, Hamano H, Okada N, Yagi K, Goda M, Nawa H, Horinouchi Y, Nakamura T, Hakuno H, Shinomiya K, Zamami Y, Azuma M, Akaike M, Ishizawa K. Aizawa F, et al. Among authors: ishizawa k. J Pharm Health Care Sci. 2024 Oct 1;10(1):61. doi: 10.1186/s40780-024-00382-6. J Pharm Health Care Sci. 2024. PMID: 39354644 Free PMC article.
Statins ameliorate oxaliplatin- and paclitaxel-induced peripheral neuropathy via glutathione S-transferase.
Aizawa F, Kajimoto H, Okabayashi A, Moriyama D, Yagi K, Takahashi S, Sonoda Y, Shibata T, Goda M, Niimura T, Izawa-Ishizawa Y, Hamano H, Kawada K, Zamami Y, Ishizawa K. Aizawa F, et al. Among authors: ishizawa k. Neurochem Int. 2024 Nov;180:105863. doi: 10.1016/j.neuint.2024.105863. Epub 2024 Sep 21. Neurochem Int. 2024. PMID: 39307458 Free article.
Unveiling the association between fluoroquinolones and aortic diseases using real-world database analysis and pharmacological experiments.
Miyata K, Izawa-Ishizawa Y, Tsujinaka K, Nishi H, Itokazu S, Miyata T, Kondo M, Yoshioka T, Niimura T, Aizawa F, Yagi K, Sato M, Hyodo M, Hamano H, Kawada K, Chuma M, Zamami Y, Tsuneyama K, Goda M, Ishizawa K. Miyata K, et al. Among authors: ishizawa k. Biomed Pharmacother. 2024 Oct;179:117418. doi: 10.1016/j.biopha.2024.117418. Epub 2024 Sep 11. Biomed Pharmacother. 2024. PMID: 39265233 Free article.
606 results